News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mathers Edward T
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Mathers Edward T (10% Owner) has filed a Form 4 on Bright Health Group Inc.|
Txns:
| Bought 828,395 warrants
@ $0.01, valued at
$8.3k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2023 |
4
| Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 06/08/2023 |
4
| Mathers Edward T (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.01, valued at
$157.7k
|
|
| 03/06/2023 |
4
| Mathers Edward T (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Acquired 5,771 shares
@ $0 |
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Mathers Edward T (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Granted 9,367 options to buy
@ $4.38, valued at
$41k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Mathers Edward T (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $4.15, valued at
$83k
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Mathers Edward T (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $2.09, valued at
$36.6k
|
|
| 04/13/2022 |
4
| Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 948,948 shares
@ $1.9, valued at
$1.8M
Granted 3,000,000 options to buy
@ $0.001, valued at
$3k
|
|
| 06/30/2021 |
4
| Mathers Edward T (10% Owner) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Converted 2,715,968 shares
@ $0
Converted 3,257,328 shares
@ $0
Converted 669,002 shares
@ $0
Bought 1,050,000 shares
@ $19, valued at
$20M
Converted 9,588,725 convertible preferred
@ $0
Converted 11,500,000 convertible preferred
@ $0
Converted 2,361,912 convertible preferred
@ $0 |
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Mathers Edward T (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $18.99, valued at
$284.9k
|
|
| 06/08/2021 |
4
| Mathers Edward T (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options to buy
@ $16.88, valued at
$287k
|
|
| 04/12/2021 |
4
| Mathers Edward T (Director) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Granted 14,000 options to buy
@ $15, valued at
$210k
|
|
| 07/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 14,210 options to buy
@ $4.1, valued at
$58.3k
|
|
| 06/15/2020 |
4
| Mathers Edward T (Director) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Granted 17,000 options to buy
@ $16.71, valued at
$284.1k
|
|
| 06/08/2020 |
4
| Mathers Edward T (Director) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.22, valued at
$33.3k
|
|
| 04/03/2020 |
4
| Mathers Edward T (Director) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 15,000 options to buy
@ $22.37, valued at
$335.6k
Disposed/sold 15,000 options to buy
@ $9.9, valued at
$148.5k
Disposed/sold 15,000 options to buy
@ $19.88, valued at
$298.2k
|
|
| 06/21/2019 |
4
| Mathers Edward T (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $22.93, valued at
$344k
|
|
| 06/13/2019 |
4
| Mathers Edward T (Director) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $19.88, valued at
$298.2k
|
|
| 06/07/2019 |
4
| Mathers Edward T (Director) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 10,000 options to buy
@ $7.3, valued at
$73k
|
|
| 05/08/2019 |
4
| Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 23,684 options to buy
@ $10, valued at
$236.8k
|
|
|
|
|